CATX logo

Perspective Therapeutics (CATX) Return On Assets

Annual ROA

-47.51%
-35.54%-296.91%

December 1, 2023

Summary

Performance

1-Year Change

-296.91%

3-Year Change

-455.02%

5-Year Change

+22.06%

15-Year Change

-17.08%

CATX ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.23%
CATX annual return on assets is higher than 41.23% of companies in Healthcare sector

High & Low

All-time High

24.95 K%
CATX annual return on assets is currently -100.19% below its historical high of 24.95 thousand%

3-Year Low

-47.51%
CATX annual return on assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CATX previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Mar 28, 2025
CATX next annual earnings announcement is scheduled for Mar 28, 2025

OtherCATXprofitabilitymetrics:

Annual Revenue

-
CATX annual revenue value is unknown

Annual Net Income

-$46.51 M
CATX annual net profit is -$46.51 million

Annual EPS

-$1.70
CATX annual earnings per share is -$1.70

Annual ROE

-61.86%
CATX annual return on equity is -61.86%

Quarterly ROA

-22.12%
+4.93%+18.23%

September 1, 2024

Summary

Performance

3-Month Change

+18.23%

1-Year Change

-21.01%

3-Year Change

-188.02%

5-Year Change

-188.02%

CATX Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.1%
CATX quarterly return on assets is higher than 62.1% of companies in Healthcare sector

High & Low

All-time High

366.75 K%
CATX quarterly return on assets is currently -100.01% below its historical high of 366.75 thousand%

3-Year Low

-40.78%

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CATX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
CATX next earnings announcement is scheduled for Mar 28, 2025

OtherCATXprofitabilitymetrics:

Quarterly Revenue

-
CATX quarterly revenue value is unknown

Quarterly Net Income

-$15.12 M
CATX quarterly net profit is -$15.12 million

Quarterly EPS

-$0.21
CATX quarterly earnings per share is -$0.21

Quarterly ROE

-26.18%
CATX quarterly return on equity is -26.18%

ROA Formula

ROA =  Net Income
Total Assets ✕ 100%

Annual ROA

-47.51%
CATX annual return on assets is -47.51%

Annual Net Income

-$46.51 M
CATX annual net profit is -$46.51 million

Annual Total Assets

$97.89 M
CATX annual total assets is $97.89 million

CATX ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-296.9%-21.0%
3 y3 years-455.0%-188.0%
5 y5 years+22.1%-188.0%

CATX ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-455.0%at low-188.0%+45.8%
5 y5-year-455.0%+22.1%-188.0%+45.8%
alltimeall time-100.2%+99.3%-100.0%+99.7%

Perspective Therapeutics ROA History

DateAnnualQuarterly
Sep 2024
-
-22.12%(-18.2%)
Jun 2024
-
-27.05%(-29.8%)
Mar 2024
-
-38.51%(-5.6%)
Dec 2023
-47.51%(+296.9%)
-40.78%(+123.1%)
Sep 2023
-
-18.28%(+21.6%)
Jun 2023
-
-15.03%(+95.7%)
Mar 2023
-
-7.68%(-44.4%)
Dec 2022
-11.97%(+11.0%)
-
Sep 2022
-
-13.82%(+28.1%)
Jun 2022
-
-10.79%(+18.6%)
Jun 2022
-10.78%(+25.9%)
-
Mar 2022
-
-9.10%(-5.6%)
Dec 2021
-
-9.64%(-8.3%)
Sep 2021
-
-10.51%(+7.9%)
Jun 2021
-8.56%(-77.5%)
-
Jun 2021
-
-9.74%(-37.6%)
Mar 2021
-
-15.62%(-52.7%)
Dec 2020
-
-33.05%(-11.5%)
Sep 2020
-
-37.36%(+0.1%)
Jun 2020
-38.03%(-37.6%)
-37.34%(+7.0%)
Mar 2020
-
-34.91%(-9.6%)
Dec 2019
-
-38.60%(-4.0%)
Sep 2019
-
-40.20%(-17.6%)
Jun 2019
-60.96%(-10.3%)
-48.79%(-21.4%)
Mar 2019
-
-62.07%(-5.4%)
Dec 2018
-
-65.58%(-3.0%)
Sep 2018
-
-67.58%(-2.7%)
Jun 2018
-67.94%(+67.4%)
-69.48%(+22.6%)
Mar 2018
-
-56.65%(+11.7%)
Dec 2017
-
-50.72%(+12.1%)
Sep 2017
-
-45.23%(+11.5%)
Jun 2017
-40.58%(+77.1%)
-40.56%(+23.3%)
Mar 2017
-
-32.89%(+11.5%)
Dec 2016
-
-29.50%(+10.6%)
Sep 2016
-
-26.68%(+17.3%)
Jun 2016
-22.92%(+54.2%)
-22.75%(+8.8%)
Mar 2016
-
-20.91%(+10.2%)
Dec 2015
-
-18.97%(+15.0%)
Sep 2015
-
-16.50%(+10.5%)
Jun 2015
-14.86%(-58.1%)
-14.93%(-12.0%)
Mar 2015
-
-16.96%(-30.3%)
Dec 2014
-
-24.34%(-13.9%)
Sep 2014
-
-28.27%(-25.7%)
Jun 2014
-35.47%(-33.0%)
-38.04%(-13.9%)
Mar 2014
-
-44.20%(-6.8%)
Dec 2013
-
-47.43%(-2.1%)
Sep 2013
-
-48.46%(+2.6%)
Jun 2013
-52.97%(+16.9%)
-47.23%(-4.0%)
Mar 2013
-
-49.18%(+5.6%)
Dec 2012
-
-46.59%(+10.9%)
Sep 2012
-
-42.02%(-7.4%)
Jun 2012
-45.33%
-45.37%(+19.3%)
Mar 2012
-
-38.04%(-10.7%)
Dec 2011
-
-42.62%(+9.1%)
DateAnnualQuarterly
Sep 2011
-
-39.05%(+10.7%)
Jun 2011
-35.91%(-12.4%)
-35.29%(-9.5%)
Mar 2011
-
-39.00%(+1.3%)
Dec 2010
-
-38.49%(-14.2%)
Sep 2010
-
-44.86%(+9.6%)
Jun 2010
-40.99%(-1.7%)
-40.93%(+6.1%)
Mar 2010
-
-38.58%(+1.1%)
Dec 2009
-
-38.15%(-3.8%)
Sep 2009
-
-39.66%(-5.6%)
Jun 2009
-41.69%(+6.9%)
-42.00%(+7.1%)
Mar 2009
-
-39.20%(+0.0%)
Dec 2008
-
-39.19%(-3.9%)
Sep 2008
-
-40.80%(+5.2%)
Jun 2008
-39.00%(-35.6%)
-38.79%(-5.8%)
Mar 2008
-
-41.19%(-8.2%)
Dec 2007
-
-44.88%(-3.7%)
Sep 2007
-
-46.59%(-26.8%)
Jun 2007
-60.54%(+40.9%)
-63.66%(-25.6%)
Mar 2007
-
-85.56%(-39.6%)
Dec 2006
-
-141.60%(-17.2%)
Sep 2006
-
-170.99%(-5.5%)
Jun 2006
-42.98%(-102.6%)
-181.01%(+34.8%)
Mar 2006
-
-134.33%(-21.0%)
Dec 2005
-
-170.02%(-12.8%)
Sep 2005
-
-195.05%(-100.6%)
Jun 2005
1683.89%(-79.4%)
-
Mar 2005
-
33.52 K%(<-9900.0%)
Dec 2004
-
-211.11%(-102.5%)
Sep 2004
8181.10%(-226.2%)
8411.11%(+8.3%)
Jun 2004
-
7766.67%(+43.8%)
Mar 2004
-
5400.00%(+40.9%)
Dec 2003
-
3833.33%(-157.5%)
Sep 2003
-6482.40%(+1.6%)
-6666.67%(-4.2%)
Jun 2003
-
-6955.56%(-0.9%)
Mar 2003
-
-7022.22%(-3.2%)
Dec 2002
-
-7255.56%(+10.3%)
Sep 2002
-6380.56%(-125.6%)
-6577.78%(-124.6%)
Jun 2002
-
26.78 K%(+4.0%)
Mar 2002
-
25.74 K%(-1.7%)
Dec 2001
-
26.19 K%(+2594.6%)
Sep 2001
24.95 K%(-463.6%)
971.90%(-396.5%)
Jun 2001
-
-327.76%(+15.9%)
Mar 2001
-
-282.89%(+1.4%)
Dec 2000
-
-278.89%(-95.8%)
Sep 2000
-6859.87%(-2309.1%)
-6570.00%(-103.7%)
Jun 2000
-
179.95 K%(+0.2%)
Mar 2000
-
179.67 K%(+0.1%)
Dec 1999
-
179.51 K%(-51.1%)
Sep 1999
310.53%(-2865.2%)
366.75 K%
Sep 1998
-11.23%(-59.8%)
-
Sep 1997
-27.91%(-76.0%)
-
Sep 1996
-116.18%(+199.4%)
-
Sep 1995
-38.80%(+155.1%)
-
Sep 1994
-15.21%
-

FAQ

  • What is Perspective Therapeutics annual return on assets?
  • What is the all time high annual ROA for Perspective Therapeutics?
  • What is Perspective Therapeutics annual ROA year-on-year change?
  • What is Perspective Therapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Perspective Therapeutics?
  • What is Perspective Therapeutics quarterly ROA year-on-year change?

What is Perspective Therapeutics annual return on assets?

The current annual ROA of CATX is -47.51%

What is the all time high annual ROA for Perspective Therapeutics?

Perspective Therapeutics all-time high annual return on assets is 24.95 K%

What is Perspective Therapeutics annual ROA year-on-year change?

Over the past year, CATX annual return on assets has changed by -35.54% (-296.91%)

What is Perspective Therapeutics quarterly return on assets?

The current quarterly ROA of CATX is -22.12%

What is the all time high quarterly ROA for Perspective Therapeutics?

Perspective Therapeutics all-time high quarterly return on assets is 366.75 K%

What is Perspective Therapeutics quarterly ROA year-on-year change?

Over the past year, CATX quarterly return on assets has changed by -3.84% (-21.01%)